Anurag Saraf, MD
@ASarafMD2
Followers
802
Following
8K
Media
41
Statuses
491
Faculty #BWH/DFCI network #radonc | #GeriOnc #meded | #columbia, #nymc, #coloradopsl #HROP alum | tweets=own
Joined July 2020
AWESOME 🔥🔥 video on #radiation treatment in honor of childhood cancer awareness month #CCAM by the amazing #MusicWithMsLiz. Excited for #pediatric #AYA advances at #ASTRO!. And a subtle @BrighamRadOnc cameo 👀. @HElhalawaniMD @kevinxliu @DHaasKogan.
1
2
8
RT @subatomicdoc: Next up @ASarafMD2 on phase II resident-med student #mentorship intervention in #radonc #MedEd . Residents checked with f….
0
4
0
Great experience to be a part of this work, now need more work in incorporating longitudinal #PROs into clinical workflow and associating with novel biomarkers like #ctDNA. So appreciate the amazing mentorship of @aparna1024 and @RyanNipp!!. @BrighamRadOnc @MGHCancerCenter.
Proud of our team Esp co 1st authors @jxj1998 (now in med school) @ASarafMD2 (new attending) for their incredible work. Started as 2017 office conversation w/ @RyanNipp when we said let’s do this. pros matter! ctDNA data coming next @MGHCancerCenter.
0
4
16
RT @aparna1024: Proud of our team Esp co 1st authors @jxj1998 (now in med school) @ASarafMD2 (new attending) for t….
0
7
0
RT @guildsman: We really need to start incorporating PROs into routine oncology practice, but no easy way to do this in our EMR still. This….
0
2
0
RT @FallowfieldLJ: This is an important paper, reinforcing yet again why PROs are not just an add-on, might be better than tumour markers!….
0
4
0
RT @BrighamRadOnc: 🪑Congratulations to @harvardmed Professor Andrea Ng MD, inaugural incumbent of the @BrighamWomens Distinguished Chair in….
0
4
0
RT @dbittermanmd: I had a great time discussing our research developing #NLP methods to actively support patients undergoing radiotherapy….
0
7
0
RT @BenjaminKannMD: 🗞️ Our latest work out today in @NatureComms . 🌟 Led by star research fellow Anna Zapaishchykova. 🧠 Automated temporali….
0
6
0
RT @GeriOncCoP: 🚨Interested in learning how to provide high-quality, guideline-driven care to older adult pts w/cancer?.📢Tune in for a join….
0
23
0
RT @A_CT_SimMDJD: Fantastic turnout for our inaugural @ASTRO_org #EarlyCareer Committee session on Developing as an Early Career practitone….
0
7
0
So honored to be invited to share on early career, such an important topic and great group of people to work with! . #ASTRO2023.@A_CT_SimMDJD @JamesBatesMD @ChelainG @jaguaranna27 @BrighamRadOnc.
Wonderful talk by @ASarafMD2 at the inaugural Early Career Professional Development session at #ASTRO23 with many great insights about key differences in mentorship, sponsorship, and benefits/challenges for early career Radiation Oncologists. Knocked it out of the park!! 💪🙌👏
1
4
39
RT @_ShankarSiva: 🧵1/ 🙏🏾🙏🏾Thank you patients, families, trial staff and investigators for participating in @TROGfightcancer.15.03 FASTRACK….
0
132
0
0
0
2
RT @BrighamRadOnc: #CCAM2023 spotlight is on Daphne Haas-Kogan, MD, the @BrighamRadOnc Chair, and much more. @DHaasKogan has decades of exp….
0
6
0
RT @DanielBRosen: How did the change in NCCN guidelines for testicular seminoma in 2012 impact outcomes? Check out our findings in the Red….
0
12
0
RT @BanlaIsmael: 1 of the first Qs I had at the start of my radonc journey on @BenjaminKannMD's service was how worried should I be abt pne….
0
6
0
RT @F_Fintelmann_MD: 🚀 your body composition research with age- and sex-adjusted reference values for skeletal muscle cross-sectional area,….
0
2
0
RT @NishantUppal7: Grateful for how much I learned from you and Dr. Himmelstein while working on this together!.
0
1
0
RT @ASTRO_org: This new #RedJournal article from @ASarafMD2 examines sarcopenia and toxicity-related discontinuation of endocrine therapy i….
0
8
0